Louisiana lawmakers are advancing legislation that could significantly change how artificial intelligence is used in payer decision-making—particularly when it comes to denying coverage. The proposed bill would require that any denial involving AI or automated systems be reviewed and approved by a qualified human clinician, ensuring decisions are based on individualized patient circumstances rather than algorithms alone.
If enacted, the policy would roll out in phases beginning in August 2026, eventually applying to all new and existing health plans by 2028. It would impact insurers, pharmacy benefit managers (PBMs), and third-party review organizations that rely on AI for utilization management.
Key provisions would prohibit AI from independently denying, delaying, or modifying care. Instead, a physician who has personally reviewed the patient’s medical record must sign off on any adverse determination. The legislation also emphasizes transparency—requiring payers to disclose when AI is used in decision-making and how much influence it had on the outcome.
Additionally, the bill strengthens patient protections. Denials influenced by AI could be presumed invalid unless supported by documented clinical judgment, and patients would have expanded rights to appeal and access information about the AI systems involved. Notably, AI tools could not be used in subsequent reviews of a claim once an appeal is filed on those grounds.
For healthcare organizations, this proposal signals a growing regulatory focus on balancing innovation with accountability—making it essential to stay informed as AI oversight continues to evolve across the payer landscape.
Resource: Louisiana bill would require human review of AI-driven coverage denials